Determinants of door-in-door-out time in patients with ischaemic stroke transferred for endovascular thrombectomy

Background: Long door-in-door-out (DIDO) times are an important cause of treatment delay in patients transferred for endovascular thrombectomy (EVT) from primary stroke centres (PSC) to an intervention centre. Insight in causes of prolonged DIDO times may facilitate process improvement interventions. We aimed to quantify different components of DIDO time and to identify determinants of DIDO time. Methods: We performed a retrospective cohort study in a Dutch ambulance region consisting of six PSCs and one intervention centre. We included consecutive adult patients with anterior circulation large vessel occlusion, transferred from a PSC for EVT between October 1, 2019 and November 31, 2020. We subdivided DIDO into several time components and quantified contribution of these components to DIDO time. We used univariable and multivariable linear regression models to explore associations between potential determinants and DIDO time. Results: We included 133 patients. Median (IQR) DIDO time was 66 (52–83) min. The longest component was CTA-to-ambulance notification time with a median (IQR) of 24 (16–37) min. DIDO time increased with age (6 min per 10 years, 95% CI: 2–9), onset-to-door time outside 6 h (20 min, 95% CI: 5–35), M2-segment occlusion (15 min, 95% CI: 4–26) and right-sided ischaemia (12 min, 95% CI: 2–21). Conclusions: The CTA-to-ambulance notification time is the largest contributor to DIDO time. Higher age, onset-to-door time longer than 6 h, M2-segment occlusion and right-sided occlusions are independently associated with a longer DIDO time. Future interventions that aim to decrease DIDO time should take these findings into account.

[1]  S. Prabhakaran,et al.  Door-In-Door-Out Process Times at Primary Stroke Centers in Chicago. , 2021, Annals of emergency medicine.

[2]  Hester F. Lingsma,et al.  Comparison of eight prehospital stroke scales to detect intracranial large-vessel occlusion in suspected stroke (PRESTO): a prospective observational study , 2021, The Lancet Neurology.

[3]  A. Alexandrov,et al.  Intravenous Thrombolysis With Tenecteplase in Patients With Large Vessel Occlusions , 2020, Stroke.

[4]  B. Clissold,et al.  Mechanical thrombectomy for emergent large vessel occlusion: an Australian primary stroke centre workflow analysis , 2020, Internal medicine journal.

[5]  J. Jeng,et al.  Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke , 2019, The New England journal of medicine.

[6]  Hester F. Lingsma,et al.  Effect of Interhospital Transfer on Endovascular Treatment for Acute Ischemic Stroke , 2019, Stroke.

[7]  Hester F. Lingsma,et al.  Personalized Prehospital Triage in Acute Ischemic Stroke , 2019, Stroke.

[8]  M. Jayaraman,et al.  Door-in-Door-Out Time at Primary Stroke Centers May Predict Outcome for Emergent Large Vessel Occlusion Patients , 2018, Stroke.

[9]  Heather B. Roesly Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging , 2018, The Journal of Emergency Medicine.

[10]  E. Lindsay Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct , 2018 .

[11]  J. Carpenter,et al.  Interhospital Transfer Before Thrombectomy Is Associated With Delayed Treatment and Worse Outcome in the STRATIS Registry (Systematic Evaluation of Patients Treated With Neurothrombectomy Devices for Acute Ischemic Stroke) , 2017, Circulation.

[12]  T. Wijeratne,et al.  Deconstruction of Interhospital Transfer Workflow in Large Vessel Occlusion: Real-World Data in the Thrombectomy Era , 2017, Stroke.

[13]  Adnan H Siddiqui,et al.  Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysis. , 2016, JAMA.

[14]  G. Andersen,et al.  Prehospital Acute Stroke Severity Scale to Predict Large Artery Occlusion: Design and Comparison With Other Scales , 2016, Stroke.

[15]  A. Demchuk,et al.  Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials , 2016, The Lancet.

[16]  J. Broderick,et al.  Design and Validation of a Prehospital Scale to Predict Stroke Severity: Cincinnati Prehospital Stroke Severity Scale , 2015, Stroke.

[17]  P. Sandercock,et al.  Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials , 2014, The Lancet.

[18]  E. López‐Cancio,et al.  Design and Validation of a Prehospital Stroke Scale to Predict Large Arterial Occlusion: The Rapid Arterial Occlusion Evaluation Scale , 2014, Stroke.

[19]  A. Demchuk,et al.  Low Rates of Acute Recanalization With Intravenous Recombinant Tissue Plasminogen Activator in Ischemic Stroke: Real-World Experience and a Call for Action , 2010, Stroke.

[20]  M. Kaste,et al.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. , 2008, The New England journal of medicine.

[21]  Endovascular thrombectomy after large-vessel ischaemic stroke: A meta-analysis of individual patient data from five randomised trials. Lancet 2016; 387:1723–31 , 2016 .

[22]  O. Adeoye,et al.  Letter by Adeoye et al Regarding Article, "Prehospital Acute Stroke Severity Scale to Predict Large Artery Occlusion: Design and Comparison With Other Scales". , 2016, Stroke.

[23]  P. Sandercock,et al.  Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials | NOVA. The University of Newcastle's Digital Repository , 2014 .